Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors

Hebei Senlang Biotechnology Inc., Ltd. · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
adultcervical-cancernsclc
solid tumor, adult, cervical cancer, sarcoma, nsclc, cd22, chimeric antigen receptor, solid tumor, tumor infiltration lymphocyte, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 891101
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.